Commercial Lead, Australia

Iovance Biotherapeutics

4d•Remote

About The Position

The Commercial Lead, Australia is the senior commercial leader accountable for establishing, commercialising and scaling Iovance Biotherapeutics’ business in Australia. The role owns the Australian commercial strategy and profit-and-loss performance for AMTAGVI and Proleukin, including revenue, operating expenses, forecasting, resource allocation and achievement of business objectives. The position directs the full sales cycle, from market development, account planning, referral generation and patient identification through treatment-centre activation, completed patient infusions, revenue generation and ongoing account growth. The Commercial Lead will lead the authorisation and commercial activation of AMTAGVI treatment centres and provide ongoing operational and quality oversight. The role builds executive and clinical relationships across treatment centres and referral networks; ensures medical, nursing, laboratory, pharmacy, quality and administrative stakeholders are prepared to deliver TIL therapy; and coordinates internal functions to move eligible patients from identification and referral through tumour procurement, manufacturing coordination, treatment scheduling, completed infusion and revenue recognition. As the senior business leader for Australia, this position sets the country commercialisation strategy, leads launch and market development, and is accountable for commercial performance and preparation for national public access. The role represents the Australian business in global planning, investment, forecasting and performance discussions, and builds commercial capabilities and the organisation as the market grows. It reports directly to the SVP, Global Access, Operations and Proleukin. The role is preferably based in Melbourne or Sydney. The successful candidate must be based in Australia, have ongoing legal working rights in Australia, hold a current driver licence and undertake regular domestic travel, anticipated to be up to 75%. Work takes place in field, remote-office, treatment-centre and other business environments and involves standard office technology and virtual and in-person meetings.

Requirements

Relevant bachelor’s degree or equivalent combination of education and senior commercial leadership experience.
Typically 12 or more years of progressive relevant experience in oncology or biotechnology commercial and customer-facing leadership roles.
Demonstrated success leading a pharmaceutical or biotechnology product launch at country or regional level.
Demonstrated profit-and-loss ownership and delivery against revenue, operating expense, budget and profitability targets.
Experience leading an end-to-end sales process tied to patient treatment, administration or infusion, including demand generation, patient conversion, completed treatment and revenue recognition.
Strong forecasting, financial planning, budget management, business analytics and performance-management experience.
Experience building a market, commercial capability or country organisation with limited existing infrastructure.
High clinical aptitude in oncology and immunotherapy, with commercial and operational acumen in tertiary hospital and community oncology settings.
Understanding of the environment and influences affecting treatment-centre providers and personnel.
Executive presence and ability to influence senior internal and external stakeholders and deliver compelling oral presentations.
Ability to manage competing priorities, make sound decisions, use appropriate discretion and meet time-sensitive business requirements.
Ability to lead through influence in a matrix organisation and build organisational capability as the Australian business grows.
Regular use of standard office technology and participation in virtual and in-person meetings.
Must be based in Australia and have ongoing legal working rights in Australia.
Current driver licence and ability to undertake regular domestic travel, anticipated to be up to 75%.

Nice To Haves

MBA or other relevant postgraduate qualification.
Cell therapy and hospital experience.
Solid tumour launch experience.
Experience developing and building service lines at public or private teaching hospitals or tertiary hospitals.
Strong understanding of transplant or cell therapy service lines.
Experience in, or demonstrated ability to learn, the cellular therapy field, including service-line operations, quality, cell laboratories and nursing.

Responsibilities

Own and lead the Australian commercialisation strategy, launch plan and ongoing business performance for AMTAGVI and Proleukin.
Hold profit-and-loss accountability for the Australian business, including revenue, operating expenses, forecasts, budgets, investments, resource allocation and profitability.
Establish annual and long-range commercial plans, performance measures and resource priorities aligned with global business objectives.
Lead the full sales cycle across authorised treatment centres and referral networks, from opportunity identification, account planning and customer education through patient identification, referral, treatment scheduling, completed infusion, revenue generation and account growth.
Achieve patient infusion, demand and revenue targets for AMTAGVI and Proleukin while complying with applicable laws, regulations and company policies.
Build and manage the Australian commercial forecast using treatment-centre readiness, referral activity, patient identification, scheduling, manufacturing, infusion and revenue data.
Develop and maintain executive, clinical and operational relationships with treatment centres, referral sites, health-service leaders, clinicians, Commonwealth and state health authorities, public and private funders, reimbursement stakeholders, hospital decision-makers and other partners.
Lead the TIL treatment-centre authorisation process using risk-based tools for authorisation, training, monitoring and disqualification, and provide ongoing operational and quality oversight of authorised centres.
Lead operational meetings with medical oncology, surgery and cell therapy leadership to establish a standard-of-care pathway for TIL therapy.
Lead cross-functional treatment-centre meetings with nursing, laboratory, pharmacy, quality and operational champions to develop product and patient workflows and remove barriers to treatment.
Develop and execute training for authorised users and ensure trained individuals receive access to chain-of-identity and chain-of-custody systems.
Lead cross-functional execution across Market Access, Treatment Centre Operations, Medical Affairs, Business Analytics, Finance, Human Resources, Legal, Supply Chain, Patient Services and global commercial teams.
Represent the Australian business in global planning, forecasting, investment and performance reviews.
Design the future Australian commercial organisation and lead selection, development and performance of additional team members as the market grows.
Lead or participate in advisory board meetings to identify market-development and educational needs.
Adhere to Iovance Biotherapeutics’ core values and business ethics and maintain compliance with corporate policies and procedures and Australian healthcare laws and regulations.
Perform other duties reasonably within the scope of the role, as required.